https://www.myjoyonline.com/mastercard-foundation-africa-cdcs-saving-lives-and-livelihoods-initiative-deliver-1-2-million-vaccines-to-ghana/-------https://www.myjoyonline.com/mastercard-foundation-africa-cdcs-saving-lives-and-livelihoods-initiative-deliver-1-2-million-vaccines-to-ghana/
President and CEO of the MasterCard Foundation, Reeta Roy

The MasterCard Foundation and Africa CDC jointly announced that 1.2 million vaccines purchased under the Saving Lives and Livelihoods initiative have landed in Ghana and are set for distribution.

The shipment is part of a first tranche of vaccines to be delivered under the initiative.

“Timely delivery of these vaccines underscores the effectiveness of the African Vaccine Acquisition Trust. Working with the Africa CDC and multiple organisations, the MasterCard Foundation will support the rollout of vaccinations to millions across the continent.

"More remains to be done to urgently increase vaccination rates. We call on all actors to step forward to save lives and livelihoods in Africa,” President and CEO of the MasterCard Foundation, Reeta Roy, told Joy Business.

Through Saving Lives and Livelihoods, the MasterCard Foundation is purchasing vaccines for more than 65 million people across Africa. The vaccines will be distributed within countries by UNICEF.

Launched in June 2021, Saving Lives and Livelihoods is now a $1.5 billion partnership that aims to enable vaccination for millions of people, develop a workforce for vaccine manufacturing, and strengthen the Africa CDC’s capacity to oversee a historic vaccination campaign and effectively respond to future outbreaks.

Director of the Africa CDC, Dr John Nkengasong revealed that “We are steadily picking up momentum in the continental vaccination effort.

"In September, the first tranche of AVAT-purchased vaccines began rolling out to 39 countries. Now we are announcing the delivery of vaccines purchased through the Saving Lives and Livelihoods initiative. And we are working hard on the ground to get jabs-in-arms, which is the ultimate measure of success”.

Vaccines purchased under Saving Lives and Livelihoods build on a historic agreement negotiated by the African Vaccine Acquisition Trust (AVAT) earlier this year for the purchase of 400 million Johnson & Johnson vaccines as well as a more recent agreement for the purchase of 50 million Moderna vaccines.

The MasterCard Foundation is expected to fund the purchase of 57 million Johnson & Johnson vaccines and is seeking to purchase approximately 17 million Moderna vaccines.

The AVAT mechanism was created to enable African countries to pool together resources to directly purchase vaccines at discounted prices made possible by volume orders.

“Through the AVAT, we have secured enough vaccines to vaccinate 450 million people by September 2022. In this regard, Africa has met its side of the bargain. So far, the Mastercard Foundation is the only foundation that has stepped up to support Africa in this work.

"They are covering AVAT’s entire November shipment—and we remain grateful for their support. We hope to see other foundations and corporations get behind the local and national delivery of vaccines,” the African Union Special Envoy, Strive Masiyiwa, stated.

Meanwhile, the President of Afreximbank, Professor Benedict Oramah has lauded the initiative as a “remarkable collaborative effort through the AVAT, which Afreximbank are proud to have played our part in. The arrangement for the supply and distribution of vaccines was configured on the back of a US$2 billion guarantee issued by Afreximbank to the vaccine manufacturers, with the support of partners. Through these combined efforts, the reopening of trade and commerce throughout the continent will be accelerated.”

The rollout of vaccines under the Saving Lives and Livelihoods initiative will be led by UNICEF, who are overseeing vaccine delivery for the overall AVAT effort. UNICEF has extensive experience delivering vaccines and a strong and well-established relationship with African countries.

UNICEF is also supporting the procurement of vaccines for the Saving Lives and Livelihoods initiative and the larger AVAT vaccine purchase effort.

DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.


DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.